UCB's Global Corporate Website
Welcome to UCB in the United States

Mar

15

Voices on Value: Building a Sustainable Healthcare System Together – Our U.S. Sustainable Access and Pricing Transparency Report

Last year, UCB launched its Voices on Value blog series to foster a dialogue around how to make our health system better, stronger, and more accessible now and in the future. To advance this dialogue, UCB is releasing its first-ever U.S. Sustainable Access and Pricing Transparency Report, which underscores UCB’s commitment to an innovative, competitive, and value-based system. 

Nov

01

Voices on Value: The importance of patient-focused value assessment, Part 2

As innovators in the healthcare industry, UCB and The Innovation and Value Initiative (IVI) believe recognizing patient voices in value assessments is important. In our recent Voices on Values series, our Head of U.S. HEOR Strategy, Edward Lee, sat down with Jennifer Bright, Executive Director at IVI to discuss how we can ensure all patient voices are captured in value assessments. Learn more about their conversation.

Oct

25

Voices on Value: The importance of patient-focused value assessment, Part 1

In order to build a world where care is more accessible to every patient, you have to put patients at the center of everything you do. UCB and The Innovation and Value Initiative (IVI) are focused on developing strategies that make patients the focal point of value assessments. Learn more about our patient centered approach from our Head of U.S. HEOR Strategy, Edward Lee, and IVI Executive Director Jennifer Bright.

Jul

20

Voices on Value: UCB’s Commitment to Transforming Access Through Value-Based Contracts

As our health care system shifts from volume- to value-based reimbursement, industry participation in value-based contracts (VBCs) is helping drive this transformation. Read more from Head of Rare Disease Access Strategy, Kelly Guntrum, on how UCB is transforming access through value-based contracts.

May

12

Voices on Value: Extending Our Focus Beyond the Medicine to Benefit Patients

As stakeholders emerge from the pandemic with newfound insights about what constitutes high-value care, it appears that more—not less—disruption may be needed. Read more from Head of U.S. Corporate Affairs, Patty Fritz, on how UCB is extending our focus beyond the medicine to deliver value for patients.